GlaxoSmithKline PLC (NYSE:GSK)‘s stock had its “neutral” rating reissued by Deutsche Bank AG in a report released on Thursday. Other equities research analysts have also recently issued reports about the company. Zacks Investment Research cut GlaxoSmithKline PLC from a “buy” rating to a “hold” rating in a research note on Tuesday, January 31st. Goldman Sachs […]
